Kenvue Inc. Common Stock vs Vanguard High Dividend Yield ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Vanguard High Dividend Yield ETF trades at $158.9 (market cap $100.80B). The key difference: Vanguard High Dividend Yield ETF is far larger — about 3× Kenvue Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals.
| KVUE | VYM | |
|---|---|---|
Market Cap | $34.06B | $100.80B |
Volume | 23,267,228 | 908,176 |
Sector | Consumer Staples | — |
52-Week High | $19.83 | $167.03 |
52-Week Low | $14.11 | $137.47 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 139 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VYM trades at $158.75, up 0.83% with a bearish technical signal from moving averages. The ETF maintains consistent dividend payments, with a recent $0.89 dividend declared for September 2026. Technical indicators show mixed signals with neutral oscillators and key support at $156. Recent media coverage highlights VYM's role in income strategies but notes competitive pressure from alternative dividend ETFs offering higher yields and performance.
VYM faces headwinds from underperformance relative to peers like SCHD and IDV, with concerns about dividend sustainability in its holdings. The ETF's broad diversification provides stability but limits upside potential. Key risks include sector concentration in dividend-cut vulnerable stocks and competitive yield pressures. Analyst sentiment remains neutral given its steady but modest income profile.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →